NEW YORK, Aug. 3 (GenomeWeb News) - PerkinElmer has signed onto a collaboration with Vivascience to create fractionation kits for proteomics-based biomarker analysis, the companies said today.
Under the agreement, the companies will combine PerkinElmer's elution chemistries with Vivascience's membrane adsorber chromatography technology to create the kits. PerkinElmer said it will then market these biomarker screening reagent kits along with its biomarker screening instruments, which include its Multiprobe II liquid handling workstation and proTOF 2000 MALDI-TOF mass spectrometer. The parties did not disclose the financial terms of the agreement.
PerkinElmer also said that Predictive Diagnostics, which recently began using PerkinElmer's proTOF for its clinical proteomics program, will have early access to the PerkinElmer/Vivascience fractionation kits through the end of the year.
Vivascience, of Hannover, Germany, produces chromatography technology that is rigid, unlike traditional resins and beads, the companies said.